Journal List > J Korean Ophthalmol Soc > v.50(9) > 1008359

Sun, Choi, and Lee: Pars Plana Vitrectomy Combined With Surgical Removal of Anterior and Posterior Capsular Opacity

Abstract

Purpose

To evaluate the efficacy and intraocular lens (IOL) stability of vitrectomy combined with the surgical removal of anterior capsular opacity (ACO) and posterior capsular opacity (PCO).

Methods

Forty-four pseudophakic eyes of 43 patients with retinal disorders underwent vitrectomy with surgical removal after cataract diagnosis. Nineteen eyes of 19 patients (group 1) had ACO and PCO removed while 25 eyes of 24 patients (group 2) had only PCO removed. Total removal of the entire lens capsule, except for the area around the haptics, was performed when capsular opacity with fibrosis was observed around the capsulorrhexis margin. LogMAR best corrected visual acuity (BCVA), intraoperative complications and postoperative complications were compared.

Results

The retina was flat and postoperative BCVA improved in both groups. Intraoperative complications of IOL dislocation occurred in 3 eyes (15.8%) in group 1 and in 1 eye (4.0%) in group 2 (p=0.178). Among the 4 IOLs, 3 were open-loop haptic IOLs and 1 was a closed-loop haptic IOL. Late postoperative complications of IOL capture occurred in 1 eye (5.3%) in group 1.

Conclusions

Removal of ACO and PCO for better visualization of the peripheral retina resulted in an improved visual recovery while intraoperative complications and postoperative complications were comparable to PCO removal alone. Removal limited to the optic zone would be more stable when considering any adhesion between the lens capsule and the IOL.

References

1. Machemer R. The development of pars plana vitrectomy: a personal account. Graefes Arch Clin Exp Ophthalmol. 1995; 233:453–68.
2. Campo RV, Sipperley JO. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1988; 105:432–4.
crossref
3. Gündüz K, Bakri SJ. Management of proliferative diabetic retinopathy. Compr Ophthalmol Update. 2007; 8:245–56.
4. Lewis H, Abrams GW, Williams GA. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987; 104:607–13.
crossref
5. Pollack A, Landa G, Kleinman G, et al. Results of combined surgery by phacoemulsification and vitrectomy. Isr Med Assoc J. 2004; 6:143–6.
6. Nawrocki J, Cisiecki S. Combined surgery, phacoemulsification, implantation of intraocular lens and pars plana vitrectomy. Klin Oczna. 2004; 106:596–604.
7. Wensheng L, Wu R, Wang X, et al. Clinical complications of combined phacoemulsification and vitrectomy for eyes with coexisting cataract and vitreoretinal diseases. Eur J Ophthalmol. 2009; 19:37–45.
crossref
8. Ogino N, Kumagai K. Advantage of combined procedure in vitreous surgery. Semin Ophthalmol. 2001; 16:137–8.
crossref
9. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol. 1992; 37:73–116.
crossref
10. Kappelhof JP, Vrensen GF. The pathology of after-cataract. A minireview. Acta Ophthalmol Suppl. 1992; 205:13–24.
11. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology. 1983; 90:1548–53.
crossref
12. Vasavada AR, Raj SM. Anterior capsule relationship of the AcrySof intraocular lens optic and posterior capsule opacification: a prospective randomized clinical trial. Ophthalmology. 2004; 111:886–94.
13. McLeod D. Giant retinal tears after central vitrectomy. Br J Ophthalmol. 1985; 69:96–8.
crossref
14. Kim SH, Chung JW, Chung H, Yu HG. Phacoemulsification and foldable intraocular lens implantation combined with vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy. J Cataract Refract Surg. 2004; 30:1721–6.
crossref
15. Weinreb RN, Wasserstrom JP, Parker W. Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol. 1986; 104:730–1.
crossref
16. Poliner LS, Christianson DJ, Escoffery RF, et al. Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients. Am J Ophthalmol. 1985; 100:637–43.
crossref
17. Park SE, Lee SJ. Mechanized posterior capsulectomy during combined vitrectomy and cataract surgery. J Korean Ophthalmol Soc. 2007; 48:1335–40.
crossref
18. Lee SJ, Choi KS, Park SH, Jung GY. A Reverse Ab Externo Scleral Fixation for Posterior Chamber Intraocular Lens Dislocation. J Korean Ophthalmol Soc. 2007; 48:1341–5.
crossref
19. Kim SJ, Lee SJ, Park CH, et al. Long-term stability and visual outcomes of a single-piece, foldable, acrylic intraocular lens for scleral fixation. Retina. 2009; 29:91–7.
crossref

Figure 1.
Anterior segment photograph of a patient with anterior and posterior capsular opacity showing a dense fibrotic change around the contractured capsulorrhexis margin.
jkos-50-1341f1.tif
Figure 2.
Surgical removal of anterior capsular opacity (ACO). (A) A broad ACO was seen preoperatively. (B) One half of the anterior capsule was cut using a bent 26G needle after confirming the degree of adhesion between the lens capsule and the IOL. (C) Another half was cut from the opposite side. (D) Then, the anterior capsule was removed through the corneal entry site. After ACO removal, the posterior capsular opacity was removed with vitreous cutter.
jkos-50-1341f2.tif
Figure 3.
Intraocular lens (IOL) stability depending on the IOL type. Anterior and posterior capsular opacity in a 3 piece open-loop haptic IOL (A) and a single piece closed-loop haptic IOL (B). The postoperative photograph of closed-loop haptic IOL seems to be more stable with its wide haptic portion (D) than the open-loop haptic IOL (C). The arrows indicate the remnant lens capsule at the hapatic portion.
jkos-50-1341f3.tif
Table 1.
Demographics of the patients
  Group 1 (n=19) Group 2 (n=25) p value
Age (years) 59.21±13.15 64.04±8.66 0.103
F/U (months) 12.05±14.75 13.56±18.14 0.424
Preop logMAR VA 1.53±1.08 1.38±1.06 0.796
Postop logMAR VA 0.74±0.39 0.95±0.81 0.043
Proliferative diabetic retinopathy 12 (63.2%) 14 (56.0%) 0.632
Macular hole 2 (10.5%) 6 (24.0%) 0.251
Epiretinal membrane 2 (10.5%) 3 (12.0%) 0.879
Rhegmatogenous retinal detachment 2 (10.5%) 2 (8.0%) 0.773
Vitreous opacity 1 (5.3%) 0 (0%) 0.246
Gas tamponade 10 (52.6%) 16 (64.0%) 0.447
Scleral buckling/encircling 4 (21.1%) 5 (20.0%) 0.932

Group 1=Removal of both anterior and posterior capsular opacity; Group 2=Removal of posterior capsular opacity only.

Statistical significance by t-test, p<0.05.

Table 2.
Types of implanted IOLs
    Group 1 (n=19) Group 2 (n=25)
1 piece IOL 570C (Rayner) 8 (1) 9
  604A (Rayner) 2 1
3 piece IOL AR40e (Advanced Medical Optics) 7 (1) 12 (1)
  Silens6 (Bausch & Lomb) 1 (1) 2
  SI40NB (Advanced Medical Optics) 1 1

Group 1=Removal of both anterior and posterior capsular opacity; Group 2=Removal of posterior capsular opacity only.

No of dropped IOL.

Table 3.
Intra- and postoperative complications
Complications   Group 1 (n=19) Group 2 (n=25) p value
Intraoperative IOL dislocation 3 (15.8%) 1 (4.0%) 0.178
  Corneal epithelial peeling 0 (0.0%) 2 (8.0%) 0.317
Postoperative Corneal edema 2 (10.5%) 9 (36.0%) 0.054
  IOL capture 1 (5.3%) none 0.246

Group 1=Removal of both anterior and posterior capsular opacity; Group 2=Removal of posterior capsular opacity only.

TOOLS
Similar articles